Timothy P. Walbert
Independent DirectorMr. Timothy P. Walbert, also known as Tim, is Chairman of Apollo Therapeutics, LLC since June 2026. He is Director of Catalent, Inc. from February 20, 2025. He has senior leadership experience building and scaling global biopharmaceutical companies, with deep expertise across rare disease, immunology, inflammation, corporate strategy and commercialization. He is Director of Catalent Pharma Solutions, Inc. He is Independent Director of BioMarin Pharmaceutical Inc. from February 24, 2025. He was Independent Director of Sagimet Biosciences Inc. from April 01, 2024 until June 12, 2026. He is Independent Director of Kardigan, Inc. from May 2026. He is Director of COUR Pharmaceuticals Development Company, Inc. from June 26, 2024. He is Independent Director of Mirum Pharmaceuticals, Inc. from April 05, 2023. He served as Independent Director of Century Therapeutics, Inc. from September 2022 until June 2026. He is Chairman of Latigo Biotherapeutics, Inc. from October 2024. He was a Director of Raptor Pharmaceutical Corp. from 2010 to 2014. He is Independent Director of Odyssey Therapeutics, Inc. from June 2024. He is Independent Director of Crystalys Therapeutics Inc. from February 2026 and is its Independent Chairman of the Board since September 2026. He is Senior Advisor of Patient Square Capital, LP from May 07, 2026. He joined the Patient Square Capital, LP on January 07, 2026. He was Lead Independent Director of Assertio Holdings, Inc. from May 19, 2020 to December 14, 2020. He was employed at Assertio Holdings, Inc. until December 14, 2020. He was Director of Sucampo Pharmaceuticals, Inc. from October 13, 2015 to 2018. He was employed at Sucampo Pharmaceuticals, Inc. from October 13, 2015 to 2018. He was Independent Director of Aurinia Pharmaceuticals Inc. from April 20, 2020 to September 2022. He was employed at Aurinia Pharmaceuticals Inc. until September 2022. He was Independent Director of XOMA Royalty Corporation. He was employed at XOMA Royalty Corporation from November 15, 2010 to May 24, 2017. He was Director of Horizon Pharmaceutical LLC from October 25, 2016. He joined the Horizon Pharmaceutical LLC on October 25, 2016. He was President & CEO of Horizon Therapeutics Public Limited Company from October 06, 2023 to October 2023. He was Chairman, President & CEO of Horizon Therapeutics Public Limited Company from March 2010 to October 06, 2023. He was employed at Horizon Therapeutics Public Limited Company from June 2008 to October 2023. He was Chief Executive Officer, President and Director of Horizon Therapeutics USA, Inc. He joined the Horizon Therapeutics USA, Inc. in July 2008. He was Independent Chairman of the Board & Lead Independent Director of Zyla Life Sciences. He was Independent Chairman of the Board of Zyla Life Sciences from June 2015. He joined the Zyla Life Sciences on March 11, 2014. He was Executive Vice President of Commercial Operations of NeoPharm, Inc. He was employed at NeoPharm, Inc. from January 18, 2006 to May 31, 2007. He was Chief Executive Officer, President and Director of IDM Pharma, Inc. He was employed at IDM Pharma, Inc. from May 2007 to June 24, 2009. He was Independent Chairman of the Board of Exicure, Inc. from April 2020 to February 04, 2022. He was Director of Exicure, Inc. from July 22, 2019 to April 2020. He is a member of the Board of Trustees of Muhlenberg College. He is also a senior advisor to Amgen. He was employed at Exicure, Inc. until February 04, 2022. He has B.A. in Business from Muhlenberg College.
Positions
- Company NameMirum Pharmaceuticals, Inc.Stock CodeMIRMPositionIndependent DirectorColleagues
- CPChristopher PeetzCEO & Director
- MGMichael G. GreyIndependent Non-Executive Chairman of the Board
- PRPeter RadovichCOO & President
- EHEric H. BjerkholtChief Financial Officer
- JGJean-Luc GirardetChief Technical Officer
- AMAndrew McKibbenSenior Vice President, Strategic Finance & Investor Relations
- LFLaurent FischerIndependent Director
- LALaura A. BregeIndependent Director
- Company NameLatigo Biotherapeutics, Inc.Stock CodeLTGOPositionIndependent ChairmanColleagues
- NKNeha KrishnamohanChief Business Officer & CFO
- TPTimothy P. WalbertIndependent Chairman
- NFNima FarzanExecutive Officer
- NKNeil Kumar SinglaChief Medical Officer
- TNTodd N. SmithPresIdent, CEO & Director
- JCJulia ChapmanSenior Vice President of Operations
- BCBeth C. SeidenbergIndependent Director
- SMSara M. BonsteinIndependent Director
- DPDeborah PalestrantIndependent Director
